Mesoblast Ltd. Files 6-K Report with SEC
Ticker: MESO · Form: 6-K · Filed: 2026-04-08T06:18:54-04:00
Sentiment: neutral
Topics: regulatory-filing, foreign-issuer
TL;DR
MESOBLAST LTD filed a 6-K on 4/8/26. Check exhibits for details.
AI Summary
On April 8, 2026, Mesoblast Ltd. filed a Form 6-K, reporting information to the SEC. The filing includes an express press release and exhibits, with the total submission text file size being 974,502 bytes. The company's mailing and business address is Level 38, 55 Collins Street, Melbourne, Victoria, C3 3000.
Why It Matters
This filing provides an update on Mesoblast Ltd.'s regulatory reporting, which is crucial for investors and stakeholders to stay informed about the company's activities and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign issuer and does not contain significant new financial or operational information that would inherently increase risk.
Key Numbers
- 974502 — Submission Text File Size (Indicates the volume of information provided in the filing.)
Key Players & Entities
- MESOBLAST LTD (company) — Filer
- 0001345099 (company) — CIK
- 2026-04-08 (date) — Filing Date
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K filing is a report of foreign issuer required by the SEC, used to provide information that the company makes public in its home country or that is otherwise distributed to its security holders.
What are the key documents included in this 6-K filing?
This filing includes an express press release (EX-99.1) and graphic exhibits (exhibit991dmd001.jpg, exhibit991dmd002.jpg, exhibit991dmd003.jpg).
What is Mesoblast Ltd.'s business address?
Mesoblast Ltd.'s business address is Level 38, 55 Collins Street, Melbourne, Victoria, C3 3000.
What is the SIC code for Mesoblast Ltd. and what does it represent?
The SIC code is 2836, which represents Biological Products, (No Diagnostic Substances).
When was this Form 6-K filing accepted by the SEC?
This Form 6-K filing was accepted by the SEC on April 8, 2026, at 06:18:54.
From the Filing
EDGAR Filing Documents for 0001345099-26-000043 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001345099-26-000043 Filing Date 2026-04-08 Accepted 2026-04-08 06:18:54 Documents 5 Period of Report 2026-04-08 Document Format Files Seq Description Document Type Size 1 6-K form6-kxpressreleasecoverf.htm 6-K 15949 2 EX-99.1 exhibit991dmd.htm EX-99.1 11503 3 exhibit991dmd001.jpg GRAPHIC 268984 4 exhibit991dmd002.jpg GRAPHIC 319961 5 exhibit991dmd003.jpg GRAPHIC 97725 Complete submission text file 0001345099-26-000043.txt 974502 Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036 MESOBLAST LTD (Filer) CIK : 0001345099 (see all company filings) EIN. : 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630 Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 26846447 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)